Abstract
Efficacy of the Individualized Coordination and Empowerment for Care Partners of Persons with Dementia (ICECaP), an intervention that involves one-on-one individualized support from a dementia care coordinator for a dementia care partner, compared to an active control group. At least once monthly contact is made from a dementia care coordinator to the dementia care partner by telephone, video conferencing, email, or in-person support at clinical visits for the person with dementia. In this pilot randomized unblinded control trial of ICECaP, n=61 (n=90 randomized) care partners completed 12-months of the ICECaP intervention and n=69 (n=92 randomized) care partners received routine clinical support (controls) in an outpatient memory care clinic at an academic medical center, from which the participants were recruited (ClinicalTrials.gov: NCT04495686, funded by Department of Defense and Virginia Department for Aging and Rehabilitative Services). Early termination endpoints (death and higher level of care) and trial drop out were comparable across groups. Primary efficacy outcomes were evaluated by comparing changes in care partner mental health, burden, and quality of life from baseline to 12-months between ICECaP and controls. Linear-mixed ANCOVA revealed no significant group differences in longitudinal changes on measures of caregiving burden, care partner depression, anxiety, quality of life, or reactions to the behavioral symptoms of the person with dementia. Hypothesized reasons for lack of initial efficacy on primary 12-month outcomes are discussed.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Clinicaltrials.gov: NCT04495686 https://clinicaltrials.gov/study/NCT04495686
Clinical Protocols
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1551714423003415?returnurl=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1551714423003415%3Fshowall%3Dtrue&referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Virginia Institutional Review Board for Health Sciences Research (IRB-HSR) approved this study and all participants were consented under HSR 190081 prior to study enrollment.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
Funding: This work was funded by the Department of Defense (AZ190036); program development and pilot feasibility testing was funded by the Virginia Department for Aging and Rehabilitative Services (45918).
REDCap support at the University of Virginia is supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award # UL1TR003015.
Conflicts of interest: None.
Registration: ClinicalTrials.gov NCT04495686 An Innovative Support Care Model for Dementia and Traumatic Brain Injury
The full trial protocol can be made available upon request.
Data Availability
Data will be shared publicly upon completion of the full trial (approximately 2026). Limited datasets may be available upon request to the University of Virginia (contact Carol Manning, cm4r{at}virginia.edu).
